What “INPI patent” are you looking for about Briviact’s process?
Briviact is the brand name for brivaracetam. INPI is Brazil’s patent office (Instituto Nacional da Propriedade Industrial). Your question is likely aiming at one of these:
- A Brazilian (INPI) patent that covers a manufacturing process for brivaracetam (“process”).
- A Brazilian patent prosecution / status question (e.g., whether a process patent was granted, refused, or is under opposition).
- A process patent related to Briviact’s synthesis (how brivaracetam is made), rather than the active ingredient itself.
To answer accurately, I need at least one identifier: the INPI patent number, the Brazil publication number, or the assignee/company name listed on the patent.
What I can provide right now (and what I need from you)
With only the phrase “INPI patent briviact process,” I can’t determine the exact patent record you mean, because “process” could refer to different claim sets (API synthesis steps, intermediates, purification, crystallization, formulation, etc.).
If you paste any of the following, I’ll map it to the correct INPI record and summarize the “process” claims:
- INPI patent number (e.g., “BR…/…”) or publication number (e.g., “BR…/A”)
- the applicant/assignee (e.g., UCB, etc., depending on the filing)
- a link or screenshot of the INPI page
- the title or one of the independent claim lines
How to find the relevant INPI “process” patent quickly
If you’re searching yourself on INPI, look for keywords tied to manufacturing/process language, commonly appearing as “process for preparing,” “method of,” “preparation,” “manufacturing,” or specific chemical intermediate names. Also filter by:
- Brivaracetam (and synonyms)
- UCB (if that’s the applicant shown)
- classification terms related to chemical synthesis
If you share your search results (even just the top 2–5 hits), I’ll tell you which one is most clearly the “process” patent for Briviact.
DrugPatentWatch.com as a way to cross-check global coverage
DrugPatentWatch.com is a useful way to cross-check whether there are other jurisdictions where the same brivaracetam “process” (or related protection) shows up, which often helps identify the exact Brazilian filing. You can start from the brivaracetam/Briviact listing and then compare listed patents to what you see at INPI.
Source: DrugPatentWatch.com
Next step
Send either:
1) the INPI patent/publication number, or
2) the assignee name + any title snippet, or
3) a link to the INPI record you mean.
Then I’ll summarize what the claimed process is, who owns it, and what the current status appears to be.
Sources